1. Home
  2. HCM vs OGCP Comparison

HCM vs OGCP Comparison

Compare HCM & OGCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • OGCP
  • Stock Information
  • Founded
  • HCM 2000
  • OGCP N/A
  • Country
  • HCM Hong Kong
  • OGCP
  • Employees
  • HCM N/A
  • OGCP 666
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • OGCP
  • Sector
  • HCM Health Care
  • OGCP
  • Exchange
  • HCM Nasdaq
  • OGCP NYSE
  • Market Cap
  • HCM 2.6B
  • OGCP 2.9B
  • IPO Year
  • HCM N/A
  • OGCP N/A
  • Fundamental
  • Price
  • HCM $14.20
  • OGCP $9.50
  • Analyst Decision
  • HCM Hold
  • OGCP
  • Analyst Count
  • HCM 1
  • OGCP 0
  • Target Price
  • HCM $19.00
  • OGCP N/A
  • AVG Volume (30 Days)
  • HCM 76.1K
  • OGCP N/A
  • Earning Date
  • HCM 02-26-2025
  • OGCP N/A
  • Dividend Yield
  • HCM N/A
  • OGCP N/A
  • EPS Growth
  • HCM N/A
  • OGCP N/A
  • EPS
  • HCM N/A
  • OGCP N/A
  • Revenue
  • HCM $610,806,000.00
  • OGCP N/A
  • Revenue This Year
  • HCM N/A
  • OGCP N/A
  • Revenue Next Year
  • HCM $20.69
  • OGCP N/A
  • P/E Ratio
  • HCM N/A
  • OGCP N/A
  • Revenue Growth
  • HCM N/A
  • OGCP N/A
  • 52 Week Low
  • HCM $11.93
  • OGCP N/A
  • 52 Week High
  • HCM $21.92
  • OGCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • HCM 42.32
  • OGCP 29.86
  • Support Level
  • HCM $13.00
  • OGCP $9.49
  • Resistance Level
  • HCM $15.29
  • OGCP $10.66
  • Average True Range (ATR)
  • HCM 0.46
  • OGCP 0.09
  • MACD
  • HCM -0.00
  • OGCP -0.02
  • Stochastic Oscillator
  • HCM 37.74
  • OGCP 0.85

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About OGCP EMPIRE STATE REALTY OP LIM PARTNER

Empire State Realty OP LP is the operating partner of Empire State Realty Inc. The company along with its partner manages, operates, acquires and repositions properties in Manhattan and the greater New York metropolitan area. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.

Share on Social Networks: